Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 Genotype with polymyalgia rheumatica

Human Immunology

Volumn 70, Issue 1, 2009, Pages 49-54

  Alvarez Rodriguez, Lorena ^a   Carrasco Marin, Eugenio ^a   Lopez Hoyos, Marcos ^a   Mata, Cristina ^b   Fernandez Prieto, Lorena ^a   Ruiz Soto, Maria ^a   Calvo, Jaime ^b   Rodriguez Valverde, Vicente ^a   Ruiz, Teresa ^b   Blanco, Ricardo ^a   Corrales, Alfonso ^c   Martinez Taboada, Victor Manuel ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c HOSPITAL DE LAREDO   (Spain)

Author keywords

Giant cell arteritis; Interleukin 1; Interleukin 1 receptor antagonist; Polymorphism; Polymyalgia rheumatica

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; RHEUMATOID FACTOR;

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ELDERLY ONSET RHEUMATOID ARTHRITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENOTYPE; GIANT CELL ARTERITIS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; TANDEM REPEAT;

AGED; AGING; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMYALGIA RHEUMATICA;

EID: 58149468067     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.10.011     Document Type: Article

References (45)

1. Martinez-Taboada V.M., Goronzy J.J., and Weyand C.M. Conceptos actuales sobre la patogenia de la arteritis de células gigantes. Rev Esp Reumatol 21 (1994) 293-299
2. Salvarani C., Cantini F., Boiardi L., and Hunder G.G. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 347 (2002) 261-271
3. Rodriguez-Valverde V., Sarabia J.M., González-Gay M.A., Figueroa M., Armona J., Blanco R., et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 102 (1997) 331-336
4. Armona J., Rodriguez Valverde V., Gonzalez-Gay M.A., Figueroa M., Fernández-Sueiro J.L., Blanco R., et al. Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc) 105 (1995) 734-737
5. Huston K.A., Hunder G.G., Lie J.T., Kennedy K.H., and Elveback L.R. Temporal arteritis. A 25 year epidemiological, clinical and pathologic study. Ann Intern Med 88 (1978) 162-167
6. Emilie D., Liozon E., Crevon M.C., Lavignac C., Portier A., Liozon F., et al. Production of interleukin 6 by granulomas of giant cell arteritis. Hum Immunol 39 (1994) 17-24
7. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
8. Arend W.P., and Guthridge C.J. Biological role of interleukin-1 receptor antagonist isoforms. Ann Rheum Dis 59 Suppl I (2000) i60-i64
9. Lecron J.C., Roblot P., Chevalier S., Morel F., Alderman E., Gombert J., et al. High circulating leukaemia inhibitory factor in patients with giant cell arteritis: Independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 92 (1993) 23-26
10. Roche N.E., Fulbright J.W., Wagner A.D., Hunder G.G., Goronzy J.J., and Weyand C.M. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 36 (1993) 1286-1294
11. Corrigal V.M., Dolan A.L., Dasgupta B., and Pahayi G.S. The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica as predictors of disease remission and steroid withdrawal. Br J Rheumatol 36 (1997) 976-980
12. Uddhammar A., Sundqvist K.G., Ellis B., and Rantapaa-Dahlqvist S. Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Br J Rheumatol 37 (1998) 766-769
13. Straub R.H., Gluck T., Cutolo M., Georgi J., Helmke K., Schölmerich J., et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumor necrosis factor) in polymyalgia rheumatica. Rheumatology 39 (2000) 624-631
14. Cutolo M., Straub R.H., Foppiani L., Prete C., Pulsatelli L., Sulli A., et al. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 29 (2002) 748-756
15. Cutolo M., Montecucco C.M., Cavagna L., Caporali R., Capellino S., Montagna P., et al. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 63 (2006) 1438-1443
16. Hernandez-Rodriguez J., Garcia-Martinez A., Casademont J., Filella X., Esteban M.J., Lopez-Soto A., et al. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum 47 (2002) 29-35
17. Roblot P., Morel F., Lelievre E., Gascan H., Wijdenes J., and Lecron J.C. Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticosteroid therapy. J Rheumatol 23 (1996) 408-410
18. Wagner A.D., Goronzy J.J., and Weyand C.M. Functional profile of tissue infiltrating and ciculating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 94 (1994) 1134-1140
19. Hernandez-Rodriguez J., Segarra M., Vilardell C., Sánchez M., Garcia-Martinez A., Esteban M.J., et al. Elevated production of interleukin 6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis. Circulation 107 (2003) 2428-2434
20. Weyand C.M., Hicok K.C., Hunder G.G., and Goronzy J.J. Tissue cytokine patterns distinguish polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 121 (1994) 484-491
21. Weyand C.M., Wagner A.D., Björnsson J., and Goronzy J.J. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 98 (1996) 1642-1649
22. Hernandez-Rodriguez J., Segarra M., Vilardell C., Sánchez M., Garcia-Martinez A., Esteban M.J., et al. Tissue production of pro-inflammatory cytokines (IL-1β, TNFα and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. Rheumatology 43 (2004) 294-301
23. Weyand C.M., Tetzlaff N., Björnsson J., Brack A., Younge B., and Goronzy J.J. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 40 (1997) 19-26
24. Straub R.H., Herfarth H.H., Rinkes B., Konecna L., Glück T., von Landerberg P., et al. Favorable role of interleukin 10 in patients with polymyalgia rheumatica. J Rheumatol 26 (1999) 1318-1325
25. Pountain G., Hazleman B., and Cawston T.E. Circulating levels of IL-1b, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giants cell arteritis and rheumatoid arthritis. Br J Rheumatol 37 (1998) 797-798
26. Dinarello C.A. Blocking IL-1 in systemic inflammation. J Exp Med 201 (2005) 1355-1359
27. Boiardi L., Salvarani C., Timms J.M., Silvestri T., Macchioni P.L., and di Giovine F.S. Interleukin-1 cluster and tumor necrosis factor-a gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol 18 (2000) 675-681
28. Gonzalez-Gay M.A., di Giovine F.S., Silvestri T., Amoli M.M., Garcia-Porrua C., Thomson W., et al. Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms in giant cell arteritis. Clin Exp Rheumatol 18 (2000) 431
29. Hacker U.T., Erhardt S., Tschöp K., Jelinek T., and Endres S. Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1β after live yellow fever vaccination. Clin Exp Immunol 125 (2001) 465-469
30. Danis V.A., Millington M., Hyland V.J., and Grennan D. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99 (1995) 303-310
31. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Edworthy S.M., et al. The American College of Rheumatology 1990 criteria for the Classification of giant cell arteritis. Arthritis Rheum 33 (1990) 1122-1128
32. Martínez-Taboada V., Brack A., Hunder G.G., Goronzy J.J., and Weyand C.M. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 23 (1996) 1011-1014
33. Chuang T.-Y., Hunder G.G., Ilstrup D.M., and Kurland L.T. Polymyalgia rheumatica: A 10- year epidemiologic and clinical study. Ann Intern Med 97 (1982) 672-680
34. González-Gay M.A., Rodríguez-Valverde V., Blanco R., Fernández-Sueiro J.L., Armona J., Blanco R., et al. Polymyalgia rheumatica without significantly increased ESR: A more benign syndrome. Arch Intern Med 157 (1997) 317-320
35. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
36. Brack A., Martínez-Taboada V.M., Stanson R., Goronzy J.J., and Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42 (1999) 311-317
37. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (1993) 403-404
38. Martínez-Taboada V.M., Bartolome M.J., Lopez-Hoyos M., Blanco R., Mata C., Calvo J., et al. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: Influence on clinical subgroups and prognosis. Semin Arthritis Rheum 34 (2004) 454-464
39. Martínez-Taboada V., Blanco R., and Rodriguez-Valverde V. Arteritis de células gigantes. Seminarios de Reumatología 1 (2000) 141-157
40. Cantini F., Niccoli L., Nannini C., Padula A., Olivieri I., Boiardi L., et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 23 (2005) 462-468
41. Cantini F., Salvarani C., Olivieri I., Niccoli L., Padula A., Macchioni L., et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: A case-control study. J Rheumatol 28 (2001) 1049-1055
42. Warle M.C., Farhan A., Metselaar H.J., Hop W.C., Perrey C., Zondervan P.E., et al. Are cytokine polymorphisms related to in vitro cytokine production profiles?. Liver Transpl 9 (2003) 170-181
43. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1RA and IL-1 beta genes. Eur J Immunol 28 (1998) 2598-2602
44. Santtila S., Savinainen K., and Hurme M. Presence of IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol 47 (1998) 195-198
45. Lopez-Hoyos M., Ruiz de Alegria C., Blanco R., Crespo J., Peña M., Rodriguez-Valverde V., et al. Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology 43 (2004) 655-657